article thumbnail

STAT+: FTC report finds PBMs profit at the expense of patients and independent pharmacies

STAT

Moreover, the FTC found the prescription drug market is “highly concentrated” because the largest PBMs are owned by insurers and, in turn, own specialty, mail order, or retail pharmacies. Continue to STAT+ to read the full story…

article thumbnail

STAT+: Pharmacies sue GoodRx and PBMs over ‘illegal’ reimbursement fees

STAT

Three independent pharmacies have filed separate lawsuits accusing GoodRx, which markets a prescription drug discount card, of conspiring with several pharmacy benefit managers to fix reimbursement fees, the latest skirmish over the opaque pharmaceutical supply chain in the U.S. and, consequently, represent a lucrative market.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

'We're scaling up hub and spoke in our independent pharmacy group'

The Pharmacist

Brothers Chris and Jonathan Lo, of Lo's Pharmacy Group, speak about why they chose a hub and spoke approach and the impact it has had on their business Lo’s Pharmacy Group, based in South Yorkshire, introduced a hub and spoke model of dispensing for their original pack repeat prescriptions over a year ago.

article thumbnail

STAT+: Wall Street wags say a bill to force insurers or PBMs to sell pharmacies has low odds

STAT

The bipartisan bill , which would require divestiture within three years, is aimed at what the lawmakers call an “inherent conflict of interest” that has forced Americans to pay more for medicines and hastened the demise of independent pharmacies.

article thumbnail

STAT+: Express Scripts sues FTC over a ‘biased’ report about pharmacy benefit managers

STAT

” The lawsuit also alleged the FTC “followed prejudice and politics, not evidence or sound economics, and wrongly concluded that PBMs inflate drug costs and harm independent pharmacies.” ” FTC Chair Lina Khan was also accused of “anti-PBM bias.”

article thumbnail

CVS and Walgreens Walkouts: What Independent Pharmacies Should Know

Digital Pharmacist

By understanding what led retail pharmacy team members to take these drastic actions, we can look at what independent pharmacies can do to avoid similar issues and also how independents can help members of these communities affected by the closures of retail chains.

article thumbnail

DIR Fee Changes Coming in 2024: The Pros and Cons for Independent Pharmacies

Digital Pharmacist

f you’re an independent pharmacy owner or pharmacist, you’re probably aware of the upcoming changes to DIR fees that will take effect in 2024. In this blog post, we will discuss the evolution of DIR fees leading up to the DIR fee changes coming in 2024, and the pros and cons independent pharmacies owners should prepare for.